The link below was taken from a post by 'wisdomofsilence' on the PRR forum today. It is pertinent to the MSB forum as well. Thanks WOS.
http://www.afr.com/p/personal_finance/portfolio/biotechs_making_steady_recovery_sZ6Y3EkaQduEbnPbuoXviK
There is an interesting quote on MSB in the article:
"But takeovers are expected to be the most likely exit strategy for most Australian biotechs, and even Mesoblast will probably end up being swallowed by a larger player. The question is how profitable can current management make the company appear before that juncture?"
I know there has been some discussion on a takeover before, but I'm happy to re-hash it. Why wouldn't someone bigger take over MSB given it's obvious potential?
afr article on aus biotechs.
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |